Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:pathogenesis:th1spectrum [02.08.2019] – [A single diagnosis for chronic inflammatory disease] sallieqhome:pathogenesis:th1spectrum [02.10.2019] – [Metabolic syndrome] sallieq
Line 494: Line 494:
 A corollary of this principle is that attempts to compare one patient's disease with another's may be futile. Certainly there is a great deal of variability in the location and severity of infection and the corresponding symptoms, but ultimately there is no fundamental difference between the origin of patients' disease states and there is, therefore, no significant difference in their ultimate recovery trajectories.  A corollary of this principle is that attempts to compare one patient's disease with another's may be futile. Certainly there is a great deal of variability in the location and severity of infection and the corresponding symptoms, but ultimately there is no fundamental difference between the origin of patients' disease states and there is, therefore, no significant difference in their ultimate recovery trajectories. 
  
-===== A trigger =====+ 
 + 
 +==== Metabolic syndrome ==== 
 + 
 +Impact of 25-hydroxyvitamin D, free and bioavailable fractions of vitamin D, and vitamin D binding protein levels on metabolic syndrome components   (({{pubmed>long:28721141}}))  
 + 
 +  
 + 
 + 
 + 
 +===== Intestinal barrier =====
  
 Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer.  (({{pubmed>long:    21248165}}))  Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer.  (({{pubmed>long:    21248165}})) 
home/pathogenesis/th1spectrum.txt · Last modified: 01.13.2024 by ron
© 2015, Autoimmunity Research Foundation. All Rights Reserved.